A major breakthrough in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in various kinds of cancer, resulting uncontrolled https://orangebookmarks.com/story22006547/vhh-fragments-reactivate-the-p53-protein-a-potential-hope-for-malignant-therapy